News | June 23, 2025
Emcure to acquire remaining stake in Zuventus Healthcare
The transaction is expected to close in Q2 FY 2026
The transaction is expected to close in Q2 FY 2026
TEMPLE, a Phase 3 multicenter, randomized, double-blind, head-to-head study, evaluated the tolerability, safety and efficacy of atogepant compared to topiramate for the preventive treatment of migraine in adult patients with a history of four or more migraine days per month
QuantumNexis will serve as the innovative engine for HCTI's recurring revenue business lines
SUP will obtain regulatory approvals for selling Tiotropium DPI in China
The project will be instrumental in enhancing the company's API manufacturing capacity and global reach
Dilip Shanghvi to continue as the Executive Chairman of the Board
This strategic expansion marks a significant step in the company's global growth strategy
The use of Apisolex polymer excipient has been proven to increase the solubility of certain APIs by as much as 50,000-fold
Honeywell Aclar film technology will enable Evertis to develop high-quality barrier packaging solutions
Globally, BRUKINSA is approved in more than 70 countries
Subscribe To Our Newsletter & Stay Updated
